Nicholas Lydon, Director at Blueprint Medicines Corp (BPMC), sold 51,414 shares at $80.44 ($4.1M) on 2020-07-06, disclosed to the SEC on 2020-07-08.
Open-market sale of $4.1M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.44 | 25,407 | $2.0M | 49.4% |
| 2 | $80.44 | 25,407 | $2.0M | 49.4% |
| 3 | $81.02 | 600 | $49K | 1.2% |
| Total | $80.45 avg | 51,414 | $4.1M | 100% |
| Filing → |
| BPMC | SELL | 2020-07-06 | $661K | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $2.1M | — | Filing → |